null

SMILES NC(=O)c1cc(F)c(N2CC3CCCN(C3C2)C(=O)C=C)c2c3ccccc3[nH]c12

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 377426   

TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Curacyte Chemistry GmbH

LigandPNGBDBM377426(Cis-4-(1-acryloyloctahydro-6H-pyrrolo[3,4-b]pyridi...)copy SMILES
Affinity DataIC50: 0.0900nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26112M3US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Curacyte Chemistry GmbH

LigandPNGBDBM377426(Cis-4-(1-acryloyloctahydro-6H-pyrrolo[3,4-b]pyridi...)copy SMILES
Affinity DataIC50: 0.200nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26112M3US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Curacyte Chemistry GmbH

LigandPNGBDBM377426(Cis-4-(1-acryloyloctahydro-6H-pyrrolo[3,4-b]pyridi...)copy SMILES
Affinity DataIC50: 0.100nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26112M3US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Curacyte Chemistry GmbH

LigandPNGBDBM377426(Cis-4-(1-acryloyloctahydro-6H-pyrrolo[3,4-b]pyridi...)copy SMILES
Affinity DataIC50: 0.100nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 ATP (20 and...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2HT2SG3US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Curacyte Chemistry GmbH

LigandPNGBDBM377426(Cis-4-(1-acryloyloctahydro-6H-pyrrolo[3,4-b]pyridi...)copy SMILES
Affinity DataIC50: 0.0900nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 ATP (20 and...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2HT2SG3US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Curacyte Chemistry GmbH

LigandPNGBDBM377426(Cis-4-(1-acryloyloctahydro-6H-pyrrolo[3,4-b]pyridi...)copy SMILES
Affinity DataIC50: 0.200nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 ATP (20 and...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2HT2SG3US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Curacyte Chemistry GmbH

LigandPNGBDBM377426(Cis-4-(1-acryloyloctahydro-6H-pyrrolo[3,4-b]pyridi...)copy SMILES
Affinity DataIC50: 0.0900nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CN76Z8US Patent